Evidence map›Paper›PMID 35893567›Full record

ArticleMicroorganisms2022

Molecular Characterization of pBOq-IncQ and pBOq-95LK Plasmids of

Armando Hernández-Mendoza, Rosalba Salgado-Morales, Abimael Morán-Vázquez, David López-Torres, Blanca Inés García-Gómez, Edgar Dantán-González

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Characterization of a novel phage-plasmid vB_EcoM_ED targeting multidrug-resistant Escherichia coli isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Armando Hernández-MendozaCentro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Cuernavaca 62210, Mexico.ORCID 0000-0002-7809-6888
Rosalba Salgado-MoralesCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Cuernavaca 62210, Mexico.ORCID 0000-0002-4870-3771
Abimael Morán-VázquezCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Cuernavaca 62210, Mexico.
David López-TorresCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Cuernavaca 62210, Mexico.
Blanca Inés García-GómezInstituto de Biotecnología, Universidad Nacional Autónoma de México, Apdo. Postal 510-3, Cuernavaca 62210, Mexico.
Edgar Dantán-GonzálezCentro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Cuernavaca 62210, Mexico.ORCID 0000-0002-3973-1244

Funding

Consejo Nacional de Ciencia y Tecnología CONACyT PDCPN 0247780
6 · The paper itself

Abstract

The increase in antimicrobial resistance has raised questions about how to use these drugs safely, especially in veterinary medicine, animal nutrition, and agriculture.

Indexed as

antibiotic resistanceevolutioninsertion sequencelysogenicphage-like

Identifiers

PMID35893567
PMCPMC9331969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.